A dominant-negative GFI1B mutation in the gray platelet syndrome
Publication year
2014Author(s)
Source
The New England Journal of Medicine, 370, 3, (2014), pp. 245-53ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Haematology
Laboratory Medicine
Laboratory of Hematology
Pathology
Cardiology
Human Genetics
Journal title
The New England Journal of Medicine
Volume
vol. 370
Issue
iss. 3
Page start
p. 245
Page end
p. 53
Subject
Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences; Radboudumc 0: Other Research RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life SciencesAbstract
The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding disorder caused by a deficiency of alpha granules in platelets. We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome. Both gray platelets and megakaryocytes had abnormal marker expression. In addition, the megakaryocytes had dysplastic features, and they were abnormally distributed in the bone marrow. The GFI1B mutant protein inhibited nonmutant GFI1B transcriptional activity in a dominant-negative manner. Our studies show that GFI1B, in addition to being causally related to the gray platelet syndrome, is key to megakaryocyte and platelet development.
This item appears in the following Collection(s)
- Academic publications [232297]
- Electronic publications [115548]
- Faculty of Medical Sciences [89118]
- Open Access publications [82846]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.